International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 4 , Pages 1088-1095 , 15 March 2009

Impact of Adding Concomitant Chemotherapy to Hyperfractionated Accelerated Radiotherapy for Advanced Head-and-Neck Squamous Cell Carcinoma

  • Sandra Nuyts, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, Leuvens Kankerinstituut, University Hospitals Leuven, campus Gasthuisberg, Leuven, Belgium
    • Corresponding Author InformationReprint requests to: Sandra Nuyts, M.D., Ph.D., Department of Radiation Oncology, Leuvens Kankerinstituut (LKI), University Hospitals Leuven, campus Gasthuisberg, Herestraat 49, B–3000 Leuven, Belgium. Tel: (+32) 16-34-7600; Fax: (+32) 16-34-7623
    • ,
  • Piet Dirix, M.D.

      Affiliations

    • Department of Radiation Oncology, Leuvens Kankerinstituut, University Hospitals Leuven, campus Gasthuisberg, Leuven, Belgium
    • ,
  • Paul M.J. Clement, M.D., Ph.D.

      Affiliations

    • Department of Medical Oncology, Leuvens Kankerinstituut, University Hospitals Leuven, campus Gasthuisberg, Leuven, Belgium
    • ,
  • Vincent Vander Poorten, M.D., Ph.D.

      Affiliations

    • Department of Otorhinolaryngology–Head and Neck Surgery, Leuvens Kankerinstituut, University Hospitals Leuven, campus Gasthuisberg, Leuven, Belgium
    • ,
  • Pierre Delaere, M.D., Ph.D.

      Affiliations

    • Department of Otorhinolaryngology–Head and Neck Surgery, Leuvens Kankerinstituut, University Hospitals Leuven, campus Gasthuisberg, Leuven, Belgium
    • ,
  • Joseph Schoenaers, M.D., Ph.D.

      Affiliations

    • Department of Maxillo–Facial Surgery, Leuvens Kankerinstituut, University Hospitals Leuven, campus Gasthuisberg, Leuven, Belgium
    • ,
  • Robert Hermans, M.D., Ph.D.

      Affiliations

    • Department of Radiology, Leuvens Kankerinstituut, University Hospitals Leuven, campus Gasthuisberg, Leuven, Belgium
    • ,
  • Walter Van den Bogaert, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, Leuvens Kankerinstituut, University Hospitals Leuven, campus Gasthuisberg, Leuven, Belgium

Received 25 March 2008 ,Revised 23 May 2008 ,Accepted 23 May 2008.

References 

  1. Parkin MD, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153–156
  2. Forastiere AA, Koch W, Trotti A, et al. Head and neck cancer. Medical progress. N Engl J Med. 2001;345:1890–1900
  3. Van den Bogaert W, van der Schueren E, Horiot JC, et al. The EORTC randomized trial on three fractions per day and misonidazole (Trial No. 22811) in advanced head and neck cancer: Long-term results and side-effects. Radiother Oncol. 1995;35:91–99
  4. Horiot JC, Bontemps P, Van den Bogaert W, et al. Accelerated compared to conventional fractionation improves loco-regional control in the RT of advanced head and neck cancer: Results of the EORTC 22851 randomized trial. Radiother Oncol. 1997;44:111–121
  5. Overgaard J, Hansen HS, Specht L, et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 & 7 randomised controlled trial. Lancet. 2003;362:933–940
  6. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation therapy for head and neck squamous cell carcinomas: First report of RTOG 90-03. Int J Radiat Oncol Biol Phys. 2000;48:7–16
  7. Bourhis J, Overgaard J, Audry H, et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: A meta-analysis. Lancet. 2006;368:843–584
  8. Nguyen LN, Ang KK. Radiotherapy for cancer of the head and neck: Altered fractionation regimens. Lancet Oncol. 2002;3:693–701
  9. Nuyts S, Dirix P, Hermans R, et al. Early experience with a hybrid accelerated radiotherapy schedule for locally advanced head and neck cancer. Head Neck. 2007;29:720–730
  10. Cooper JS, Ang K. Concomitant chemotherapy and radiation therapy certainly improves local control. Int J Radiat Oncol Biol Phys. 2005;61:7–9
  11. Pignon JP, Bourhis J, Domenge C, et al. MACH-NC Collaborative Group Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. Lancet. 2000;355:949–955
  12. Bourhis J, Amand C, Pignon JP MACH-NC Collaborative Group. Update of the MACH-NC (Meta-Analysis of Chemotherapy in Head & Neck Cancer) database focused on concomitant chemoradiotherapy. [Abstract] J Clin Oncol. 2004;22(Suppl):S5505
  13. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med. 1998;338:1798–1804
  14. Wendt TG, Grabenbauer GG, Rödel CM, et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study. J Clin Oncol. 1998;16:1318–1324
  15. Jeremic B, Shibamoto Y, Milicic B, et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial. J Clin Oncol. 2000;18:1458–1464
  16. Dobrowsky W, Naudé J. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers. Radiother Oncol. 2000;57:119–124
  17. Staar S, Rudat V, Stuetzer H, et al. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy—Results of a multicentric randomized German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;50:1161–1171
  18. Huguenin P, Beer KT, Allal A, et al. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy. J Clin Oncol. 2004;22:4665–4673
  19. Budach V, Stuschke M, Budach W, et al. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: Final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 prospective randomized trial. J Clin Oncol. 2005;23:1125–1135
  20. Ang KK, Harris J, Garden AS, et al. Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: Radiation Therapy Oncology Group phase II trial 99-14. J Clin Oncol. 2005;23:3008–3015
  21. Beckmann GK, Hoppe F, Pfreunder L, et al. Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer. Head Neck. 2005;27:36–43
  22. Bensadoun RJ, Bénézery K, Dassonville O, et al. French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC). Int J Radiat Oncol Biol Phys. 2006;64:983–994
  23. Budach W, Hehr T, Budach V, et al. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer. 2006;6:28
  24. American Joint Committee on Cancer. Cancer staging manual. 6th ed.. New York: Springer-Verlag; 2002;
  25. Maes A, Weltens C, Flamen P, et al. Preservation of parotid function with uncomplicated conformal radiotherapy. Radiother Oncol. 2002;63:203–211
  26. Bussels B, Maes A, Hermans R, et al. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer. Radiother Oncol. 2004;72:119–127
  27. Dirix P, De Keyzer F, Vandecaveye V, et al. Diffusion-weighted magnetic resonance imaging to evaluate major salivary gland function before and after radiotherapy. Int J Radiat Oncol Biol Phys. E-pub ahead of print 25 Mar 2008.
  28. Bernier J. Alteration of radiotherapy fractionation and concurrent chemotherapy: a new frontier in head and neck oncology?. Nat Clin Pract Oncol. 2005;2:305–314
  29. Dirix P, Nuyts S, Vanstraelen B, et al. Post-operative intensity-modulated radiotherapy for malignancies of the nasal cavity and paranasal sinuses. Radiother Oncol. 2007;85:385–391
  30. Tsao AS, Garden AS, Kies MS, et al. Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck. J Clin Oncol. 2006;24:4163–4169
  31. Jeremic B, Milicic B, Dagovic A, et al. Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, non-metastatic squamous cell carcinoma of the head and neck. J Clin Oncol. 2004;22:3540–3548
  32. Hoebers FJP, Heemsbergen W, Balm AJM, et al. Concurrent chemoradiation with daily low dose cisplatin for advanced stage head and neck carcinoma. Radiother Oncol. 2007;85:42–47

 Supported in part by grants from the Flemish League against Cancer and the Belgian Foundation against Cancer and the Clinical Research Fund. Piet Dirix is a research assistant (aspirant) of the Research Foundation–Flanders.

 Conflict of interest: none.

PII: S0360-3016(08)00954-1

doi: 10.1016/j.ijrobp.2008.05.042

International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 4 , Pages 1088-1095 , 15 March 2009

Article Tools

* Image Usage & Resolution